Factors associated with cardiovascular deaths, non-fatal myocardial infarction and revascularisation procedures in 465 patients with coronary artery disease
| Univariate analysis | Multivariate analysis | |||
| Factors | HR (95% CI) | p Value | HR (95% CI) | p Value |
| Fatty liver | 0.93 (0.52 to 1.66) | 0.79 | ||
| Age (years) | 1.00 (0.97 to 1.03) | 0.98 | ||
| Male gender | 0.87 (0.46 to 1.65) | 0.67 | ||
| Smoking | 1.53 (0.87 to 2.71) | 0.14 | ||
| Alcohol | 0.96 (0.43 to 2.15) | 0.93 | ||
| Diabetes | 1.88 (1.07 to 3.31) | 0.029 | 1.50 (0.83 to 2.72) | 0.18 |
| Hypertension | 1.04 (0.57 to 1.92) | 0.90 | ||
| Systolic blood pressure (mm Hg) | 0.99 (0.98 to 1.00) | 0.13 | ||
| Diastolic blood pressure (mm Hg) | 0.98 (0.96 to 1.00) | 0.064 | ||
| Body mass index (kg/m2) | 1.01 (0.94 to 1.08) | 0.90 | ||
| Waist circumference (cm) | 1.02 (0.98 to 1.05) | 0.35 | ||
| Fasting glucose (mmol/l) | 0.99 (0.87 to 1.12) | 0.86 | ||
| Total cholesterol (mmol/l) | 0.76 (0.57 to 1.00) | 0.049 | 0.92 (0.53 to 1.58) | 0.75 |
| HDL-cholesterol (mmol/l) | 0.38 (0.13 to 1.07) | 0.067 | ||
| LDL-cholesterol (mmol/l) | 0.65 (0.46 to 0.93) | 0.017 | 0.77 (0.40 to 1.50) | 0.44 |
| Triglycerides (mmol/l) | 0.83 (0.62 to 1.13) | 0.24 | ||
| Creatinine (μmol/l) | 1.002 (1.001 to 1.004) | 0.003 | 1.002 (1.001 to 1.004) | 0.006 |
| Alanine aminotransferase (IU/l) | 1.00 (0.99 to 1.01) | 0.65 | ||
| Drug use | ||||
| Aspirin | 0.94 (0.29 to 3.02) | 0.91 | ||
| Clopidogrel | 1.15 (0.60 to 2.21) | 0.68 | ||
| Statin | 1.24 (0.63 to 2.42) | 0.54 | ||
| Treatment of coronary artery disease | ||||
| Medical therapy alone | Referent | – | ||
| Percutaneous coronary intervention | 1.28 (0.57 to 2.87) | 0.55 | ||
| Bypass grafting | 0.53 (0.11 to 2.53) | 0.42 | ||
HDL, high-density lipoprotein; LDL, low-density lipoprotein.